About Crossbow Therapeutics
Expanding the reach of antibody therapeutics. Crossbow Therapeutics is determined to revolutionize the reach of cancer treatment by developing potent and precise therapies that can target the entire universe of cancer antigens.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Cambridge, United States
Team Size
11-50
Tracked Since
Sep 29, 2026
Web & Domain Identity
Official Website
crossbowtx.com
Domain Registered Date
Jul 23, 2021
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $77,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $80,000,000 · Series-A
- Milestone
Website domain registered
crossbowtx.com
Investors & Backers
Arkin Bio Ventures
Biotechnology Value Fund
Blood Cancer United, Inc.
Eli Lilly
Hamilton Square Partners Management
Mirae Asset Capital
Mirae Asset Venture Investment
MPM BioImpact
MPM Capital
Pfizer Venture Investments
Polaris
Sixty Degree Capital
Taiho Ventures
Funding History
Series-B+
· Mar 26, 2026
$77,000,000 fundraisingfox.com
Series-A
· Jul 11, 2023
$80,000,000 Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026